NEW YORK— Biotechnology company Horizon Pharma PLC asked Depomed Inc. to set a shareholder vote for its hostile takeover offer and is filing a lawsuit challenging the company's "poison pill" plan. In July, Dublin- based Horizon Pharma boosted its offer for drugmaker Depomed to $33 per share from a prior offer of $29.95 per share. Newark, California- based Depomed...» Read More
Liberty Global is looking to expand its European footprint by acquiring Germany's largest cable television operator, reports CNBC's David Faber.
D.E Master Blenders 1753 said on Thursday it received a 6.4- billion-euro takeover offer from German investor Joh A Benckiser, sending shares of the Dutch coffee and tea maker up more than 25 percent.
CNBC's Kayla Tausche reports Wonder Bread and other brands won't be auctioned in court on Thursday.
Royalty Pharma has made a $6.6 billion bid to buy Elan, seeking to scupper the drugmaker's plan to spend most of the proceeds from a major drug sale on deals.
CNBC's Jim Cramer thinks a successful social media company should be purchased by Facebook. (3:31)
Alan Lok, Director at Sabio Global says TCC will do a good job if they succeed in taking over F&N.
The "Squawk on the Street" news crew discusses the top market moving stories of the day, including a drop in demand for Apple products; an increase in the payroll tax; and UPS abandoning its takeover for TNT.
Reuters is reporting that private equity firms targeted Legg Mason but were spurned. CNBC's Courtney Reagan and FMHR discuss. Also, Erik Ristuben, Russell Investments, weighs in on how far the bull market can run.
CNBC's Andrew Ross Sorkin reports Third Point's Dan Loeb has bought more than a five percent stake in Herbalife.
CNBC's David Faber reports on continuing downsizing on Wall Street, and Dish Network's unsolicited takeover bid for Clearwire.
The "Squawk on the Street" news crew reports on the market moving stories of the day, including Alcoa's earnings; and the Dish Network's unsolicited takeover bid for Clearwire.
Brian Modoff, Deutsche Bank analyst, breaks down the BlackBerry maker's better-than-expected Q3 earnings, and discusses the outlook for the company's newest device, the BB10.
Harvey Pitt, Kalorama Partners CEO, explains why the merger of ICE and the NYSE has a high likelihood of passing regulators.
Richard Repetto, Sandler O'Neill explains how the merger could impact trading activity, and the likely candidates for the top executive spot.
CNBC's David Faber reports the latest details on a deal where the NYSE will merger with rival IntercontinentalExchange.
"Samsung and Microsoft would be the two most likely" acquirers of Research in Motion, said Peter Misek, Jefferies & Company, providing a preview of the tech company's earnings, and weighing in on the launch of BlackBerry 10.
In a fresh offer aimed at resolving the "fiscal cliff" standoff, President Barack Obama seeks $1.2 trillion from higher tax revenues, including higher rates on those earning more than $400,000 a year.
William 'Bill' George, former Medtronic chairman & CEO, discusses whether the big box store's founder, Richard Schulze, will be successful in his bid to take the company private.
The "Squawk on the Street" news crew discusses the Fed's new policy decisions; Sprint's Clearwire proposal; and news of a formal takeover bid for Best Buy.
Greece's bond buyback scheme failed to meet its target by a relatively narrow margin on Tuesday but still left international lenders with a 450-million euro hole in their plan to cut the country's huge debts to a more manageable level.